Eling Pharmaceutical (002603.SZ) announced results for the first three quarters, with net profit of 1,096 billion yuan to mother, an increase of 9.55% over the previous year

According to Zhitong Finance App, Eling Pharmaceutical (002603.SZ) released its report for the third quarter of 2026. The company achieved operating income of 5.968 billion yuan in the first three quarters, up 1.72% year on year; net profit attributable to shareholders of listed companies was 1,096 billion yuan, up 9.55% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1.06 billion yuan, up 9.68% year on year; basic earnings per share were 0.656 yuan.